These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8471323)

  • 61. Secondary myelodysplastic syndrome following bone marrow transplantation: report of two cases.
    Chan T; Juneja S; Wolf M; Januszewicz E; Cooper I
    Bone Marrow Transplant; 1994 Feb; 13(2):145-8. PubMed ID: 7515740
    [TBL] [Abstract][Full Text] [Related]  

  • 62. One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study.
    Rivkin SE; Green S; Metch B; Jewell WR; Costanzi JJ; Altman SJ; Minton JP; O'Bryan RM; Osborne CK
    J Clin Oncol; 1993 Sep; 11(9):1710-6. PubMed ID: 8355037
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adjuvant chemotherapy in postmenopausal women: results of sequential noncross-resistant regimens.
    Brambilla C; Rossi A; Valagussa P; Bonadonna G
    World J Surg; 1985 Oct; 9(5):728-37. PubMed ID: 3840630
    [No Abstract]   [Full Text] [Related]  

  • 64. Poor outcome of patients with resectable breast cancer receiving adjuvant high-dose sequential chemotherapy following preoperative treatment.
    Zambelli A; Da Prada GA; Pedrazzoli P; Ponchio L; Robustelli della Cuna G
    Anticancer Res; 1999; 19(3B):2373-6. PubMed ID: 10472359
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.
    Misset JL; di Palma M; Delgado M; Plagne R; Chollet P; Fumoleau P; Le Mevel B; Belpomme D; Guerrin J; Fargeot P; Metz R; Ithzaki M; Hill C; Mathé G
    J Clin Oncol; 1996 Apr; 14(4):1136-45. PubMed ID: 8648368
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study.
    Budd GT; Green S; O'Bryan RM; Martino S; Abeloff MD; Rinehart JJ; Hahn R; Harris J; Tormey D; O'Sullivan J
    J Clin Oncol; 1995 Apr; 13(4):831-9. PubMed ID: 7707108
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Combined modality treatment of locally advanced breast cancer: adjuvant combination chemotherapy with and without doxorubicin.
    Casper ES; Guidera CA; Bosl GJ; Hakes TB; Kaufman RJ; Shurgot B; Kinne DW
    Breast Cancer Res Treat; 1987; 9(1):39-44. PubMed ID: 3593990
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.
    Aisner J; Cirrincione C; Perloff M; Perry M; Budman D; Abrams J; Panasci L; Muss H; Citron M; Holland J
    J Clin Oncol; 1995 Jun; 13(6):1443-52. PubMed ID: 7751891
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of advanced breast cancer with chemotherapy.
    Ward JH; Eyre HJ
    Semin Surg Oncol; 1988; 4(4):256-60. PubMed ID: 3073490
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults.
    Fanin R; Silvestri F; Geromin A; Cerno M; Infanti L; Zaja F; Barillari G; Savignano C; Rinaldi C; Damiani D; Baccarani M
    Leuk Lymphoma; 1997 Jan; 24(3-4):369-77. PubMed ID: 9156668
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer.
    Wallerstein R; Spitzer G; Dunphy F; Huan S; Hortobagyi G; Yau J; Buzdar A; Holmes F; Theriault R; Ewer M
    J Clin Oncol; 1990 Nov; 8(11):1782-8. PubMed ID: 2121909
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trial.
    Muss HB; White DR; Richards F; Cooper MR; Stuart JJ; Jackson DV; Rhyne L; Spurr CL
    Cancer; 1978 Nov; 42(5):2141-8. PubMed ID: 363253
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer.
    Touboul E; Buffat L; Lefranc JP; Blondon J; Deniaud E; Mammar H; Laugier A; Schlienger M
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1019-28. PubMed ID: 8600084
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cisplatin plus VP-16 combination chemotherapy in advanced refractory breast cancer.
    Içli F; Günel N; Dinçol D; Karaoğuz H; Demirkazik A
    J Surg Oncol; 1992 Aug; 50(4):251-3. PubMed ID: 1640710
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recurrent disseminated retinoblastoma treated by high-dose chemotherapy, total body irradiation, and autologous bone marrow rescue.
    Saarinen UM; Sariola H; Hovi L
    Am J Pediatr Hematol Oncol; 1991; 13(3):315-9. PubMed ID: 1793158
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Autotransplantation in solid tumors.
    Spitzer G
    Blood Rev; 1991 Jun; 5(2):105-11. PubMed ID: 1912755
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Metastatic breast cancer: higher versus low dose maintenance treatment when only a partial response or a no change status is obtained following doxorubicin induction treatment. An Eastern Cooperative Oncology Group study.
    Falkson G; Gelman RS; Glick J; Falkson CI; Harris J
    Ann Oncol; 1992 Nov; 3(9):768-70. PubMed ID: 1450067
    [No Abstract]   [Full Text] [Related]  

  • 79. Clinical trials in advanced breast cancer.
    Schwartsmann G; Pinedo HM
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):595-7. PubMed ID: 3653182
    [No Abstract]   [Full Text] [Related]  

  • 80. Mitoxantrone, vincristine, and 5-fluorouracil with leucovorin modulation as induction chemotherapy prior to high-dose intensification in metastatic breast cancer.
    Williams SF; Myers SE; Huffman S; Mick R; Bitran JD
    Breast Cancer Res Treat; 1993 Dec; 28(3):291-4. PubMed ID: 8018957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.